Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
A completed real-world study assessed the effectiveness of nivolumab plus chemotherapy as neoadjuvant therapy for non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies [Phase 2]
A Phase 2 trial evaluating the combination of RMC-4630 and sotorasib in KRAS G12C-mutant non-small cell lung cancer after prior therapies ha…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma [Phase 2]
Phase 2 trial update evaluating Firmonertinib combined with definitive radiotherapy for stage III unresectable EGFR uncommon mutant non-smal…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating Gimistotug (BGB-A445) in combination with other investigational agents for non-small cell lung cancer has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: C-TIL051 in Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating C-TIL051 for metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC [Phase 2]
Phase 2 trial evaluating personalized radiotherapy dose redistribution for stage III non-small cell lung cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment [NA]
This clinical trial update analyzes how 18-FDG uptake changes over time in patients with stage III/IV non-small cell lung cancer treated wit…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating the combination of NXP900 with Osimertinib for advanced EGFR-mutated non-small cell lung cancer is currently recr…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer [NA]
The clinical trial evaluating parametric imaging in positron emission tomography for a patient with Non-Small Cell Lung Cancer has completed…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma [Phase 2]
Phase II study evaluating the combination of durvalumab, doxorubicin, and ifosfamide in pulmonary sarcomatoid carcinoma (a form of non-small…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 study of JAB-3312 in adults with advanced solid tumors has been completed, evaluating multiple tumor indications.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of HBI-8000 (tucidinostat) in combination with pembrolizumab for non-small cell lung cancer was terminated. Results have been …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer
A completed clinical trial update investigating predictive factors for response to a regimen of immunotherapy plus chemotherapy in non-small…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating the combination of dacomitinib and osimertinib for patients with advanced EGFR-mutant non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment [Phase 2]
A Phase 2 trial evaluating targeted post-surgery radiation therapy for non-small cell lung cancer patients with remaining lymph node cancer …
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients [NA]
A completed clinical trial examined detection of plasma DNA in patients with non-small cell lung cancer and small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy [Phase 3]
Phase 3 trial comparing Pyrotinib to Docetaxel in adults with advanced non-squamous non-small cell lung cancer harboring a HER2 exon 20 muta…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE) [Phase 2]
A Phase 2 trial of furmonertinib for EGFR-mutant non-small cell lung cancer with brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Tubeless VATS for Lung Cancer Surgery [NA]
A completed clinical trial evaluating tubeless video-assisted thoracoscopic surgery (VATS) for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A phase 2 clinical trial evaluating the combination of amivantamab and lazertinib for metastatic or recurrent non-small cell lung cancer has…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Toripalimab Combined With SBRT for NSCLC [Phase 2]
Phase 2 trial evaluating toripalimab in combination with stereotactic body radiotherapy for non-small cell lung cancer is active/not recruit…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers [Phase 1, Phase 2]
A Phase 1/2 clinical trial of SLC-391 in combination with pembrolizumab for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Lorlatinib Continuation Study [Phase 4]
Pfizer's Lorlatinib continuation study (Phase 4) for Non-Small-Cell Lung Cancer is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC [Phase 3]
LUNAR-2 is a Phase 3 trial evaluating Tumor Treating Fields (TTFields) with pembrolizumab and platinum-based chemotherapy for metastatic non…